tachipirina flasht 12 tablets 250ml
< Span Style = "Font-Size: Medium;"> pharmacotrapeutic category:
analgesic and antipyretic, anilids .
each orodisperedable tablet contains paracetamol 500 mg (like Cris Talli of Paracetamol coated). > etcipient I:
Coattermolian crystals coated: Copolimero Metacrilato Buttolato B asico; dispersion of polychrified at 30%; silica, colloidal hydrophoba.
tablet: mannitolo (granules, dust), crospovidone, aspartame (E9 51), ribes aroma, magnesium stearate.
symptomatic treatment of mild to moderate pain and/or of the febbr e.
< Font style = "vertical-align: inherit;"> hypersensitivity to paracetamol or to any of the excipients and lenthers.
phenylchetonuria (due to the presence of aspartame).
severe hepocellular cenza insuffes.
this medicine is only for adults.
The maximum recommended dosage is 3000 mg of paracetamol per day, corresponding to 6 tablets and daily.
the usual dosage is 1 500 mg tablet, from an ethereal rip if necessary after no less than four hours.
In the case of Forte do lori or high fever, 2 500 mg tablets to be repeated if necessary I give no less than four hours.
Do not exceed 6 500 mg tablets in and 24 hours.
Maximum recommended dosage: the total dose of paracetamus must not exceed the 3 g per day for adults.
frequency of top inisting: in adults the administration must be performed at intervals of at least 4 hours.
renal failure: in case of severe renal insufficiency, the interval between 2 administrations must be at least 8 hours.
way of administration: oral officer.
The tablet must be and sucked and not chewed.
it can be dispersed in the middle of the eating of water.
this medicine does not require any particular condition of conservation.
Do not exceed the recommended dose.
prolonged use of the product, other than medical supervision, can be harmful.
This product must be used only if strictly necessary.
doses higher than that and recommended involve a risk of very serious liver damage.
A treatment with an antidote must be carried out as soon as possible.
pe r avoid the risk of overdose, notify patients to avoid the contemporary use of other medicines containing paracetamol.
Quest or medicinal talks contains aspartame, a source of phenylalanine, equivalent and 0.2 mg per tablet and, therefore, is contraindicated in subjects affected by phenylchetonuria. < br> the paracetamolo must be used with Cautel a in case of: adults weighing less than 50 kg; llular hepatoce failure from mild to moderate (note: the paracetamol is contraindicated in cases of severe hepiocellular failure); chronic alcoholism; chronic nutrition (low reserves of liver glutathione); dehydrate; severe renal failure (creatinine clearance & lt; = 10 ml/min).
In the event of a high fever, or of signs of secondary infection, or of the ersistence of symptoms over 3 days, a rival must be carried out.
During prolonged treatment with analgesic farm acm, carried out with doses higher than those provided in the illustrative fo, headache may not be treated that must not be treated with higher doses of the medicine. >
in general, The usual use of analgesics, especially the combination of different analgesic drugs, may involve permanent kidney lesions with the risk of renal failure (analgesic nephropathy).
In case this sitation manifested or the onset is suspected, you need to consult your doctor and stop treatment.
the diagnosis of" analgesic headache "head" must be taken into consideration in those patients who suffer from frequent or daily headaches despite (or for) the regular use of drugs for headaches. < /font>
Probenecid causes a reduction of at least 2 times of the Clearance de l Paracetamol through the inhibition of its conjugation with the glucuronic acid.
In case of concomitant treatment with probenecid, a reduction in the dosage of paracetamol must be considered.
Cilamide salts can prolong the elimination of paracetamol elimination.
p aracedemol must be used with caution in the event of concomitant intake of enzymatic inductors (such as carbamazepine, phenobarbital, phene ina, primidone, rifampicin, hypericum or grass of San Giovanni) or potentially hepatotoxic supports.
Metoclopramide and Domperidone: accel were the absorption of paracetamol.
cholestiramine: reduces the mentally absorption of paracetamol.
concomitant use of paracetamol (4 g per day for at least 4 days) with oral anticoagulants can induce light variations in the inr values with consequent increase in the risk of watermelon.
In these cases, a more frequent monitoring of INR values during concomitant use and after its interruption must be conducted.
interactions with clinical tests: the administration of P Aracetamol can alter the dosage of uric acid in the blood, opt enute with the phosphotong acid method, and the dosage of the ciamia obtained with the oxidase method glucose peroxidase.
< Font style = "vertical-align: inherit;"> unwanted effects:
rare (from & gt; = 1/10000 a & lt; 1/1000): increase in the elli of liver transaminases.
disorders of the immune system.
very rare (& lt; 1/10000), not known: reaction of hypersensitivity (from the simpli erupy or urticaria simpli, up to the anaphylactic shock applicant nor the interruption of the treatment).
pathologies of the ethical emolinfopoi system.
very rare, not known: trombocytopenia, leukopenia, neutropenia (sporadic reports).
pregnancy and breastfeeding:
epidemiological data on the use of oral therapeutic duties of paracetamol or do not show undesirable effects on pregnancy or health of the fetus/newborn.
perspective data on pregnancies exposed to overdoseness did not highlight an increase in the risk of malformations.
Stud i on the reproduction performed with oral administration has not shown any malformation or fetus-toxic effects.
Consequently, in normal conditions of use, paracetamol can be used in the pregnancy course after an evaluation of the risk-ben ratio.
during pregnancy, the paracetamol must not be taken for Long periods, at high doses or in association with other nali doctors, since the safety of use in these cases has not been unrelated.
After oral administration, paracetamol is excreted in breast milk in small quantities.
no effects and unwanted effects on breastfed children have been reported.
The therapeutic doses of this medicine can be taken during breastfeeding.